MENLO THERAPEUTICS INC's ticker is MNLO and the CUSIP is 586858102. A total of 1 filers reported holding MENLO THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,536,000 | -40.2% | 887,959 | -7.4% | 0.00% | -100.0% |
| Q1 2020 | $2,569,000 | +2323.6% | 958,686 | +4061.7% | 0.00% | – |
| Q4 2019 | $106,000 | +241.9% | 23,036 | +231.4% | 0.00% | – |
| Q3 2019 | $31,000 | +933.3% | 6,952 | +1276.6% | 0.00% | – |
| Q2 2019 | $3,000 | -98.9% | 505 | -98.6% | 0.00% | – |
| Q1 2019 | $280,000 | -24.5% | 35,621 | -60.4% | 0.00% | – |
| Q4 2018 | $371,000 | -45.2% | 90,050 | +31.0% | 0.00% | – |
| Q3 2018 | $677,000 | +509.9% | 68,753 | +401.3% | 0.00% | – |
| Q2 2018 | $111,000 | -79.4% | 13,715 | -4.5% | 0.00% | – |
| Q1 2018 | $540,000 | – | 14,361 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DSC Advisors, L.P. | 4,359,030 | $7,541,000 | 8.27% |
| Healthcare Value Capital, LLC | 1,700,000 | $2,941,000 | 7.51% |
| 683 Capital Management, LLC | 5,550,208 | $9,602,000 | 0.77% |
| Perceptive Advisors | 22,876,410 | $39,576,000 | 0.64% |
| Vivo Capital, LLC | 3,643,824 | $6,304,000 | 0.45% |
| Monashee Investment Management LLC | 1,005,000 | $1,739,000 | 0.26% |
| MYDA Advisors LLC | 93,300 | $161,000 | 0.10% |
| Sofinnova Investments, Inc. | 725,571 | $1,256,000 | 0.08% |
| CAAS CAPITAL MANAGEMENT LP | 1,185,501 | $2,051,000 | 0.07% |
| Grace Capital | 36,012 | $62,000 | 0.05% |